Women with Systemic Lupus Erythematosus (SLE) are prone to cardiovascular disease. Early detection of improvement of endothelial function with simvastatin could be a clue for future intervention trials.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
4
simvastatin 20mg daily at nights for 12 weeks. Tablets
placebo daily at nights for 12 weeks. Tablets
Change From Baseline in Endothelial Thickness After 12 Weeks of Treatment.
The study was terminated; no outcome measure data analyses were conducted.
Time frame: Baseline and 12 weeks
Change in Total Cholesterol From Baseline at Week 12
The study was terminated; no outcome measure data analyses were conducted.
Time frame: Baseline and 12 weeks
Change From Baseline in Low Density Lipoprotein Cholesterol (LDL-C) After 12 Weeks of Treatment
The study was terminated; no outcome measure data analyses were conducted.
Time frame: Baseline and 12 weeks
Change From Baseline in High Density Lipoprotein Cholesterol (HDL-C) After 12 Weeks of Treatment
The study was terminated; no outcome measure data analyses were conducted.
Time frame: Baseline and 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.